Emergency contraception in Canada: An overview and recent developments

Canadian Journal of Human Sexuality

Volumn 16, Issue 3-4, 2007, Pages 129-133

  Pancham, Anna ^a   Dunn, Sheila ^b  

^a Planning and Policy   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL; POSTCOITUS CONTRACEPTIVE AGENT;

BIRTH CONTROL; CANADA; DEREGULATION; DRUG SAFETY; EMERGENCY CONTRACEPTION; HEALTH CARE; HEALTH CARE COST; HEALTH HAZARD; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; PHARMACIST; PREGNANCY; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE;

EID: 39749114418     PISSN: 11884517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Arowojolu, A.O., Okewole, I.A., & Adekunle, A.O. (2002). Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. Contraception, 66, 269-273.
2. Bracken, M.B. (1990). Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstetrics & Gynecology, 76, 552-557.
3. Croxatto, H.B., Devoto, L., Durant, M., Excurra, E., Larrea, F., Nagle, C. et al. (2001). Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception, 63, 111-121.
4. Dunn, S., & Guilbert, E. (2003). SOGC Clinical Practice Guidelines: Emergency Contraception. Obstetrics & Gynecology, 131, 1-7.
5. Ellertson, C., Evans, M., Ferden, S., Leadbetter, C., Spears, A., Johnstone, K. et al. (2003). Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstetrics & Gynecology, 101, 1168-1171.
6. Erdman, J.N., & Cook, R.J. (2006). Protecting fairness in women's health: The case of emergency contraception. In C. Flood (Ed.), Just Medicare: What's In, What's Out, How We Decide (pp. 137-167). Toronto, ON: University of Toronto Press.
7. Fasoli, M., Parazzini, F., Cecchetti, G., & La Vecchia, C.(1989). Post-coital contraception: an overview of published studies. Contraception, 39, 459-468.
8. Fisher, W., Boroditsky, R., & Morris, B. (2004).The Canadian Contraception Study: Part 1. Journal of Obstetrics and Gynaecology Canada, 26, 580-590.
9. Glasier, A., & Baird, D. (1998). The effects of self-administering emergency contraception. New England Journal of Medicine, 339, 1-4.
10. Henshaw, S.K. (1998). Unintended pregnancy in the United States. Family Planning Perspectives, 30, 24-29, 46.
11. Ho, P.C., & Kwan, M.S.W. (1993). A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Human Reproduction, 8, 389-392.
12. Jones, R.K., Darroch, J.E., & Henshaw, S.K. (2002). Contraceptive use among U.S. women having abortions in 2000-2001. Perspectives on Sexual and Reproductive Health, 34, 294-303.
13. Killick, S.R., & Irving, G. (2004). A national study examining the effect of making emergency hormonal contraception available without prescription. Human Reproduction, 19, 553-557.
14. Lippes, J., Malik, T., & Tatum, H.J. (1976). The postcoital copper-T. Advances in Planned Parenthood, 11, 24-29.
15. Moreau, C., Bouyer, J., Goulard, H., & Bajos, N. (2005). The remaining barriers to the use of emergency contraception: Perception of pregnancy risk by women undergoing induced abortions. Contraception, 71, 202-207.
16. Okewole, I.A., Arowojolu, A.O., Odusoga, O.L., Oloyede, O.A., Adeleye, O.A., Salu, J., & Dada, O.A. (2007). Effect of single administration of levonorgestrel on the menstrual cycle. Contraception, 75, 372-377.
17. Raymond, E.G., Trussell, J., & Polis, C.B. (2007). Population effect of increased access to emergency contraceptive pills. Obstetrics & Gynecology, 109, 181-188.
18. Rodrigues, I., Grou, F., & Joly, J. (2001). Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected intercourse. American Journal of Obstetrics & Gynecology, 184, 531-537.
19. Shoveller, J., Chabot, C., Soon, J.A., & Levine, M. (2007). Identifying barriers to emergency contraception use among young women from various socio-cultural groups in British Columbia, Canada. Perspectives on Sexual and Reproductive Health, 39, 13-20.
20. Soon, J.A., Levine, M., Osmond, B.L., Ensom, M.H., & Fielding, D.W. (2005). Effects of making emergency contraception available without a physician's prescription: A population-based study. Canadian Medical Association Journal, 172, 878-883.
21. Statistics Canada. (2004). Induced Abortions Statistics. Available at: http://www.statcan.ca/english/freepub/82-223-XIE/2007000/bfrontl.htm.
22. Task Force on Postovulatory Methods of Fertility Regulation. (1998). Randomized controlled trial of levonorgestrel versus Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet, 352, 428-433.
23. Trussell, J., Rodriguez, G., & Ellertson, C. (1998). New estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception, 57, 363-369.
24. Trussell, J., Rodriguez, G., & Ellertson, C. (1999). Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception, 59, 147-151.
25. Trussell, J., & Ellertson, C. (1995). Efficacy of emergency contraception. Fertility Control Reviews, 4, 8-11.
26. United Nations Development Programme Task Force on Post-Ovulatory Methods for Fertility Regulation. (2000). Efficacy and side effects of immediate post-coital levonorgestrel used repeatedly for contraception. Contraception, 61, 303-308.
27. Von Hertzen, H., Piaggio, G., Ding, J., Chen, J., Song, S., Bartfai, G. et al. (2002). Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomized trial. Lancet, 360, 1803-1810.
28. Zhow, L.Y., & Ziao, B.L. (2001). Emergency contraception with Multiload Cu-375 SL IUK: a multicenter clinical trial. Contraception, 264, 107-12.